Page last updated: 2024-08-20

protocatechualdehyde and Cardiac Failure

protocatechualdehyde has been researched along with Cardiac Failure in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Jia, P; Li, Y; Liu, Y; Long, K; Sun, T; Wang, C; Wang, S; Yang, Y; Zhang, H; Zhao, Y; Zheng, X; Zhi, W; Zhou, J1
Guo, Q; Jiang, Y; Liu, D; Tu, PF; Wan, YJ; Zeng, KW1

Other Studies

2 other study(ies) available for protocatechualdehyde and Cardiac Failure

ArticleYear
Guanxining injection alleviates fibrosis in heart failure mice and regulates SLC7A11/GPX4 axis.
    Journal of ethnopharmacology, 2023, Jun-28, Volume: 310

    Topics: Animals; Chromatography, Liquid; Drugs, Chinese Herbal; Fibrosis; Glycine; Heart Failure; Mice; Rosmarinic Acid; Salvia miltiorrhiza; Tandem Mass Spectrometry; Vanillic Acid

2023
Protocatechualdehyde reduces myocardial fibrosis by directly targeting conformational dynamics of collagen.
    European journal of pharmacology, 2019, Jul-15, Volume: 855

    Topics: Animals; Benzaldehydes; Catechols; Cell Line; Collagen; Fibrosis; Heart Failure; Mice; Mice, Inbred C57BL; Myocardium; Protein Conformation

2019